Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report.

Literature DB >> 2600061

Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report.

J B Weilburg¹, J F Rosenbaum, J Biederman, G S Sachs, M H Pollack, K Kelly.

Abstract

Thirty depressed outpatients poorly responsive to various non-MAOI antidepressants had fluoxetine added to their regimens. Retrospective analysis revealed that 26 (86.7%) of the patients improved. Non-MAOI antidepressant treatment was withdrawn for 12 of the 26 responders; of these, 8 relapsed on fluoxetine treatment alone but recovered when treatment with the discontinued non-MAOI agent was restarted.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1989 PMID： 2600061

Source DB: PubMed Journal: J Clin Psychiatry ISSN： 0160-6689 Impact factor: 4.384

Keyword Cloud
Cited

13 in total

1. Effects of milnacipran in animal models of anxiety and memory.

Authors: Vânia K M Moojen; Márcio Rodrigo Martins; Adalisa Reinke; Gustavo Feier; Fabiano R Agostinho; Edson M Cechin; João Quevedo
Journal: Neurochem Res Date: 2006-05-09 Impact factor: 3.996

Review 2. The Black Book of Psychotropic Dosing and Monitoring.

Authors: Alan F Schatzberg; DeBattista Charles
Journal: Psychopharmacol Bull Date: 2018-01-15

3. Antidepressant failure: augmentation or substitution?

Authors: R T Joffe; A J Levitt
Journal: J Psychiatry Neurosci Date: 1995-01 Impact factor: 6.186

4. A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.

Authors: Frances R Levin; John Mariani; Daniel J Brooks; Martina Pavlicova; Edward V Nunes; Vito Agosti; Adam Bisaga; Maria A Sullivan; Kenneth M Carpenter
Journal: Addiction Date: 2013-03-21 Impact factor: 6.526

5. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.

Authors: Antonio Tundo; Rocco de Filippis; Luca Proietti
Journal: World J Psychiatry Date: 2015-09-22

Review 6. Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

Authors: Christian Dolder; Michael Nelson; Andrea Stump
Journal: Drugs Aging Date: 2010-08-01 Impact factor: 3.923

Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report.

1. Effects of milnacipran in animal models of anxiety and memory.

Review 2. The Black Book of Psychotropic Dosing and Monitoring.

3. Antidepressant failure: augmentation or substitution?

4. A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.

5. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.

Review 6. Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

Review 7. Severe depression: is there a best approach?

Review 8. Therapeutic options for treatment-resistant depression.

Review 9. Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression.

Review 10. Obsessive-compulsive disorder in elderly patients.